Delivering
the future of
ophthalmic
medicine

PolyActiva is focused

on providing unique biodegradable implants with sustained drug delivery to improve patient outcomes and quality of life for patients suffering from ophthalmic diseases such as glaucoma.

Learn more about PolyActiva

PreziaTM

The versatile Prezia Sustained Drug Delivery Technology platform is based on extensive scientific research that has resulted in the creation of a unique method for precise and controlled drug delivery.

Learn more about Prezia

News

PolyActiva presents positive clinical trial results at the 2022 American Glaucoma Society Annual Meeting – March 2022

Read more

PolyActiva announces positive Phase IIa results in glaucoma trial with low dose cohort.

Read more
More News

Contact Us

For more information on PolyActiva, please complete the form below: